Higher numbers of alterations that were found to be associated negatively with CD8+ T cells were observed most commonly in breast cancer (26/78), followed by esophagogastric cancer (25/78) (Supplementary Figure S4, Supplementary Table S6). The gene discussed is CD8A; the disease is breast carcinoma.